Calling for benefit-risk evaluations of COVID-19 control measures. Kampf G, Kulldorff M. Lancet 2021 Feb 4. pii: S0140-6736(21)00193.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kampf G, Kulldorff M. Calling for benefit-risk evaluations of COVID-19 control measures. Lancet 2021 Feb 4. pii: S0140-6736(21)00193.
PMID: 33549169